Cargando…
Long-term Follow-up of Qing-Dai–Induced Pulmonary Arterial Hypertension: A Case Series
Autores principales: | Matsushima, Takahide, Hiraide, Takahiro, Momoi, Mizuki, Shinya, Yoshiki, Anzai, Atsushi, Inami, Takumi, Fukuda, Keiichi, Kataoka, Masaharu, Ieda, Masaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10591121/ https://www.ncbi.nlm.nih.gov/pubmed/37876881 http://dx.doi.org/10.1016/j.cjco.2023.07.012 |
Ejemplares similares
-
TET2 Variants in Japanese Patients With Pulmonary Arterial Hypertension
por: Hiraide, Takahiro, et al.
Publicado: (2021) -
RNF213-Associated Vascular Disease: A Concept Unifying Various Vasculopathies
por: Hiraide, Takahiro, et al.
Publicado: (2022) -
Impact of additional selexipag on prostacyclin infusion analogs in patients with pulmonary arterial hypertension
por: Momoi, Mizuki, et al.
Publicado: (2022) -
Triple oral combination therapy with macitentan, riociguat, and
selexipag for pulmonary arterial hypertension
por: Momoi, Mizuki, et al.
Publicado: (2021) -
TNFRSF13B c.226G>A (p.Gly76Ser) as a Novel Causative Mutation for Pulmonary Arterial Hypertension
por: Shinya, Yoshiki, et al.
Publicado: (2021)